This competitive renewal application is to investigate VPS35 (vacuolar protein sorting 35)?s function and mechanism in the pathogenesis of Alzheimer?s disease (AD). AD is the most common cause of dementia and the 6th leading cause of death in the USA. It is pathologically characterized by ?-amyloid (A?) deposits, neurofibrillary tangles, reactive glial-associated chronic inflammation, and pyramidal neuronal loss. Although A? is considered as a key mediator of the disease, recent studies suggest that the development of this complex disorder is regulated and contributed by multiple factors. VPS35-dysfunction is identified as one of the critical risk factors for AD. It is thus of considerable interest to investigate if and how VPS35-dysfunction promotes AD development. We have previously demonstrated that hemizygous deletion of the Vps35 gene in Tg2576 mice, a model of AD, precipitates A?-associated phenotypes [elevated A??levels, enhanced deficits in glutamatergic neurotransmission, long-term potentiation (LTP) in hippocampus, and memory impairment]. To explore underlying mechanisms, we first queried brain cell types that express VPS35. VPS35 is abundant in pyramidal neurons and microglia, both of which have been implicated in AD pathology. We then used knockdown (KD) and conditional knock out (cKO) approaches to investigate VPS35?s function. VPS35 KD or cKO in embryonic hippocampus led to axon spheroid formation, impairment in dendritic terminal growth, and decrease of spine density, phenotypes associated with neurodegenerative pathology. These phenotypes were development- specific, as KO VPS35 in embryonic (Vps35Nex), but not postnatal (Vps35Camk2a), pyramidal neurons resulted in these deficits.
In Aim 1, we will address how VPS35-deficiency in developing pyramidal neurons causes neurodegenerative phenotypes. In addition to pyramidal neuronal VPS35, we investigated microglial VPS35?s function in AD pathology. Using a microglial selective Vps35 KO mouse line, Vps35CX3CR1, we found that microglial VPS35 is necessary to prevent hippocampal microglial activation and promote adult hippocampal neurogenesis, malfunction of both processes involved in AD pathogenesis.
In Aim 2, we will further investigate if and how VPS35-loss in microglia contributes to AD pathogenesis. It is our hope that the results from this project will allow us to not only elucidate molecular and cellular mechanisms of VPS35 in AD development, but also open new avenues for therapeutic intervention to delay or prevent AD progression.

Public Health Relevance

NARRITIVE This study will investigate both pyramidal neuronal and microglial VPS35?s functions in the pathogenesis of Alzheimer?s disease (AD). Results will reveal insights into AD pathogenesis and contribute to better early diagnostic and therapeutic strategies for AD.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Project (R01)
Project #
2R01AG045781-06
Application #
9747597
Study Section
Cell Death in Neurodegeneration Study Section (CDIN)
Program Officer
Yang, Austin Jyan-Yu
Project Start
2014-05-01
Project End
2024-01-31
Budget Start
2019-05-01
Budget End
2020-01-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Neurosciences
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Appel, Joanna Ruth; Ye, Shiyang; Tang, Fulei et al. (2018) Increased Microglial Activity, Impaired Adult Hippocampal Neurogenesis, and Depressive-like Behavior in Microglial VPS35-Depleted Mice. J Neurosci 38:5949-5968
Wang, Ya-Nan; Figueiredo, Dwight; Sun, Xiang-Dong et al. (2018) Controlling of glutamate release by neuregulin3 via inhibiting the assembly of the SNARE complex. Proc Natl Acad Sci U S A 115:2508-2513
Sun, Xiang-Dong; Chen, Wen-Bing; Sun, Dong et al. (2018) Neogenin in Amygdala for Neuronal Activity and Information Processing. J Neurosci 38:9600-9613
Shen, Chengyong; Li, Lei; Zhao, Kai et al. (2018) Motoneuron Wnts regulate neuromuscular junction development. Elife 7:
Ye, Xin-Chun; Hu, Jin-Xia; Li, Lei et al. (2018) Astrocytic Lrp4 (Low-Density Lipoprotein Receptor-Related Protein 4) Contributes to Ischemia-Induced Brain Injury by Regulating ATP Release and Adenosine-A2AR (Adenosine A2A Receptor) Signaling. Stroke 49:165-174
Sun, Dong; Sun, Xiang-Dong; Zhao, Lu et al. (2018) Neogenin, a regulator of adult hippocampal neurogenesis, prevents depressive-like behavior. Cell Death Dis 9:8
Garrett, Andrew M; Jucius, Thomas J; Sigaud, Liam P R et al. (2016) Analysis of Expression Pattern and Genetic Deletion of Netrin5 in the Developing Mouse. Front Mol Neurosci 9:3
Huang, Zhihui; Wang, Ying; Hu, Guoqing et al. (2016) YAP Is a Critical Inducer of SOCS3, Preventing Reactive Astrogliosis. Cereb Cortex 26:2299-2310
Huang, Zhihui; Hu, Jinxia; Pan, Jinxiu et al. (2016) YAP stabilizes SMAD1 and promotes BMP2-induced neocortical astrocytic differentiation. Development 143:2398-409
Xiong, Lei; Xia, Wen-Fang; Tang, Fu-Lei et al. (2016) Retromer in Osteoblasts Interacts With Protein Phosphatase 1 Regulator Subunit 14C, Terminates Parathyroid Hormone's Signaling, and Promotes Its Catabolic Response. EBioMedicine 9:45-60

Showing the most recent 10 out of 18 publications